<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02515760</url>
  </required_header>
  <id_info>
    <org_study_id>S-515/2013</org_study_id>
    <nct_id>NCT02515760</nct_id>
  </id_info>
  <brief_title>Tumor-specific T Cells in Lung Cancer</brief_title>
  <official_title>Tumor-specific Effector T Cells in Non-small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-small cell lung cancer is characterized by aggressive growth and treatment resistance.
      New approaches include immunotherapeutic strategies but spontaneous immune responses against
      tumor antigens remain unclear. The aim of this study is to characterize localization and
      frequencies of spontaneously induced memory T cells specific for a panel of tumor-associated
      antigens in peripheral blood and bone marrow of non-small cell lung cancer patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequencies of tumor-specific T cells</measure>
    <time_frame>2 weeks postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumor-specific T cells location (peripheral versus bone marrow) determined by Enzyme Linked Immuno Spot Assay (ELISPOT) analysis of peripheral blood and bone marrow samples from the same patient</measure>
    <time_frame>2 weeks postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term survival</measure>
    <time_frame>5 years postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Lung cancer group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bone marrow puncture in patients with non-small cell lung cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group (healthy donors)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bone marrow puncture in healthy donors</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bone marrow aspiration from the iliac crest</intervention_name>
    <arm_group_label>Lung cancer group</arm_group_label>
    <arm_group_label>Control group (healthy donors)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Illinois bone marrow aspiration neddle</intervention_name>
    <arm_group_label>Lung cancer group</arm_group_label>
    <arm_group_label>Control group (healthy donors)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histology proven non-small cell lung cancer or a lesion suspicious of
             non-small cell lung cancer (lung cancer group)

          -  Healthy donors (control group)

          -  written informed consent

        Exclusion Criteria:

          -  Autoimmune disease

          -  Patients receiving immunomodulatory drugs, e.g. tacrolimus

          -  Prior malignancy

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Hoffmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seyer Safi, MD</last_name>
    <phone>004962213960</phone>
    <email>seyer.safi@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seyer Safi, MD</last_name>
      <phone>004962213960</phone>
      <email>seyer.safi@med.uni-heidelberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Hoffmann, MD, PhD</last_name>
      <phone>004962213960</phone>
      <email>hans.hoffmann@med.uni-heidelberg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Reissfelder C, Stamova S, Gossmann C, Braun M, Bonertz A, Walliczek U, Grimm M, Rahbari NN, Koch M, Saadati M, Benner A, Büchler MW, Jäger D, Halama N, Khazaie K, Weitz J, Beckhove P. Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis. J Clin Invest. 2015 Feb;125(2):739-51. doi: 10.1172/JCI74894. Epub 2014 Dec 22. Erratum in: J Clin Invest. 2015 Mar 2;125(3):1364.</citation>
    <PMID>25562322</PMID>
  </reference>
  <reference>
    <citation>Schmitz-Winnenthal FH, Volk C, Z'graggen K, Galindo L, Nummer D, Ziouta Y, Bucur M, Weitz J, Schirrmacher V, Büchler MW, Beckhove P. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Res. 2005 Nov 1;65(21):10079-87.</citation>
    <PMID>16267034</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>August 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2015</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Dr. med. Seyer Safi</investigator_full_name>
    <investigator_title>Prof. Dr. med. Hoffmann</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

